Trials / Completed
CompletedNCT03839602
Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal Carcinoma Patients
Delineation of Reducing Clinical Target Volume for Early-stage Nasopharyngeal
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To analyze the long-term results and toxicities of the reducing clinical target volume (CTV) delineation method in early-stage nasopharyngeal carcinoma (NPC) patients treated with intensity modulated radiation therapy (IMRT).
Detailed description
The investigators designed a prospective phase II study for early-stage NPC patients, and proposed a reasonable delineation method of reducing CTV according to the clinical characteristics and tumor infiltration patterns, performing therapeutic dose to tumor and prophylactic dose to CTV while protecting as much normal tissues as possible, in order to ensure a long-term survival with good quality of life.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Reducing CTV | CTVs were delineated in line with tumor stage, i.e. tumor invasion. |
Timeline
- Start date
- 2001-05-01
- Primary completion
- 2006-10-31
- Completion
- 2018-01-01
- First posted
- 2019-02-15
- Last updated
- 2019-02-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03839602. Inclusion in this directory is not an endorsement.